Anavex Life Sciences Corp.
Stock Forecast, Prediction & Price Target
Anavex Life Sciences Corp. Financial Estimates
Anavex Life Sciences Corp. Revenue Estimates
Anavex Life Sciences Corp. EBITDA Estimates
Anavex Life Sciences Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $14.37M Low: $14.37M High: $14.37M avg. 0% | Avg: $3.4M Low: $3.4M High: $3.4M avg. -76.35% | Avg: $49M Low: $49M High: $49M avg. 1341.17% | Avg: $4M Low: $4M High: $4M avg. -91.83% |
Net Income
% change YoY
| $-47.97M N/A | $-47.50M 0.98% | $-43.00M 9.47% | Avg: $-51.06M Low: $-51.06M High: $-51.06M avg. -18.74% | Avg: $-30.31M Low: $-30.31M High: $-30.31M avg. 40.62% | Avg: $-6.38M Low: $-6.38M High: $-6.38M avg. 78.94% | Avg: $-40.69M Low: $-40.69M High: $-40.69M avg. -537.50% |
EBITDA
% change YoY
| $-50.08M N/A | $-55.75M -11.32% | $0 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.62 N/A | -$0.6 3.22% | -$0.52 13.33% | Avg: -$0.64 Low: -$0.64 High: -$0.64 avg. -23.07% | Avg: -$0.38 Low: -$0.38 High: -$0.38 avg. 40.62% | Avg: -$0.08 Low: -$0.08 High: -$0.08 avg. 78.94% | Avg: -$0.51 Low: -$0.51 High: -$0.51 avg. -537.5% |
Operating Expenses
% change YoY
| $50.98M N/A | $55.75M 9.35% | $52.87M -5.16% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Anavex Life Sciences Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -109.16% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -51.06M, average is -51.06M and high is -51.06M.
What is Anavex Life Sciences Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 293.24% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $14.37M, average is $14.37M and high is $14.37M.
What is Anavex Life Sciences Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -110.25% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.64, average is -$0.64 and high is $-0.64.